Showing results (471-480 of 559) with videos related to

Sort By:
Pageof 56
JAMA Dermatology|May 18, 2017
Pediatric Psoriasis Comorbidity Screening GuidelinesEmily Osier, Audrey S Wang, Megha M Tollefson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 10, 2015
Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational StudyHaley B Naik, Balaji Natarajan, Elena Stansky, et al.
Annals of Neurology|August 5, 2014
Spinal cord gray matter atrophy correlates with multiple sclerosis disabilityRegina Schlaeger, Nico Papinutto, Valentina Panara, et al.
Journal of Neurology|November 30, 2016
Continuous daily assessment of multiple sclerosis disability using remote step count monitoringV J Block, A Lizée, E Crabtree-Hartman, et al.
The Journal of Experimental Medicine|August 27, 2014
Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLDMichael E Ward, Alice Taubes, Robert Chen, et al.
The Journal of Investigative Dermatology|May 20, 2025
Residual Inflammation in Patients with Psoriasis Treated with Biologic Therapy: Findings from 3 Prospective Observational CohortsAlba Lecumberri, Emilio Berna-Rico, Joel M Gelfand, et al.
Dermatology and Therapy|June 10, 2019
Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic CohortMary Patricia Smith, Karen Ly, Quinn Thibodeaux, et al.
Journal of the American Academy of Dermatology|November 6, 2007
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl, Jerry Bagel, Joel M Gelfand, et al.
Journal of the American Academy of Dermatology|September 28, 2014
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical settingJunko Takeshita, Shuwei Wang, Daniel B Shin, et al.
Pageof 56